MRI Characteristics of Brain Lymphoma
Brain lymphoma demonstrates characteristic MRI features including hypointense lesions on T1-weighted imaging, isointense to hypointense appearance on T2-weighted imaging, restricted diffusion with reduced apparent diffusion coefficient (ADC), variable surrounding edema, and homogeneous strong enhancement with gadolinium contrast. 1, 2
Key MRI Features to Identify
Signal Characteristics
- T1-weighted sequences: Lesions appear hypointense (darker than normal brain tissue) 1
- T2-weighted sequences: Lesions are isointense to hypointense (similar to or darker than normal brain tissue) 1
- Diffusion-weighted imaging (DWI): Shows restricted diffusion with reduced ADC values, reflecting high cellularity 1, 2
- Contrast enhancement: Strong, homogeneous enhancement is characteristic after gadolinium administration 1, 2
Anatomical Distribution Patterns
The most common locations to examine include 1:
- Frontal lobe and cerebral hemispheres (38% of cases)
- Thalamus or basal ganglia (16%)
- Corpus callosum (14%)
- Periventricular regions (12%)
- Cerebellum (9%)
- Meninges (16%)
- Spinal cord (1%)
Multifocality
- 40-50% of patients present with multifocal disease on standard MRI, which is an important distinguishing feature 1
- Multiple lesions should raise suspicion for lymphoma over other diagnoses
Recommended MRI Protocol
Contrast-enhanced cranial MRI is the mandatory imaging modality for suspected CNS lymphoma. 1, 2 The International PCNSL Collaborative Group (IPCG) protocol should be followed, utilizing either 3T or 1.5T MRI with 1:
- Diffusion-weighted sequences
- Perfusion-weighted scans
- Volumetric protocols
- Gadolinium contrast administration
Critical Diagnostic Considerations
Corticosteroid Effect
- Avoid corticosteroids before imaging and biopsy whenever clinically possible, as they cause rapid tumor regression and can make lesions disappear on MRI, leading to false-negative results 1
- If corticosteroids have been administered, repeat MRI after stopping them may be necessary before biopsy 1
Differential Diagnosis Challenges
The combined use of MRI and biomarkers helps distinguish lymphoma from 1:
- Toxoplasmosis (especially in HIV-positive patients) 1
- Brain metastases
- Non-necrotic brain tumors
- Abscesses
- Tumefactive demyelination
- Neuroinflammatory diseases
HIV-Associated Lymphoma Considerations
- In HIV-positive patients, contrast enhancement remains highly sensitive (96.1%) at diagnosis 3
- FDG-PET/CT can help differentiate cerebral infections like toxoplasmosis from CNS lymphoma, though biopsy remains the gold standard 1
- MRI is the optimal method for staging CNS lymphomas in HIV patients, but may give false-positive results due to opportunistic infections 1
Limitations and Pitfalls
- Imaging alone cannot definitively diagnose CNS lymphoma—histopathological confirmation via stereotactic biopsy remains essential 1
- Contrast-enhanced CT can be used only in patients with MRI contraindications, but is inferior to MRI 1
- Variable surrounding edema may be present, which is not specific to lymphoma 1